![Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments - Zobdeh - 2021 - British Journal of Pharmacology - Wiley Online Library Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments - Zobdeh - 2021 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/c8a94044-0f65-4dbe-9798-593b82078ea5/bph15657-fig-0003-m.jpg)
Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments - Zobdeh - 2021 - British Journal of Pharmacology - Wiley Online Library
![Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials - Journal of the Neurological Sciences Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a5250be-21f0-40d2-8efe-b1fcb33179b6/gr1_lrg.jpg)
Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials - Journal of the Neurological Sciences
![European Headache Federation on Twitter: "Cognitive dysfunction has recently gained attention as a significant problem among migraine sufferers, a review discussing a range of clinical studies that investigate the extent of cognitive European Headache Federation on Twitter: "Cognitive dysfunction has recently gained attention as a significant problem among migraine sufferers, a review discussing a range of clinical studies that investigate the extent of cognitive](https://pbs.twimg.com/media/FElS6PRXMAIrMUl.jpg:large)
European Headache Federation on Twitter: "Cognitive dysfunction has recently gained attention as a significant problem among migraine sufferers, a review discussing a range of clinical studies that investigate the extent of cognitive
![Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies | Novartis Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies | Novartis](https://novartis.gcs-web.com/system/files-encrypted/nasdaq_kms/inline-images/Aimoving%20cuts-540.jpg)